| et 99 years
- | Country :
- France
- | organs :
- Prostate
- | Specialty :
- Thérapies Ciblées
Extract
AFFIRM: A multinational phase 3, randomized, double-blind, placebo-controlled efficacy and safety study of oral MDV3100 in patients with progressive castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy.
Scientific Abstract
en cours d'intégration;